title: Oncogene-derived peptides: a new class of tumor rejection antigens?
authors.affiliation: Institute of Transplantation Immunology, National Hospital, Oslo, Norway.
authors.forename: T
authors.initials: T
authors.lastname: Gedde-Dahl
authors.forename: B H
authors.initials: BH
authors.lastname: Olsen
authors.forename: E
authors.initials: E
authors.lastname: Thorsby
authors.forename: G
authors.initials: G
authors.lastname: Gaudernack
mesh_terms: D000595:Amino Acid Sequence; D000911:Antibodies, Monoclonal / Q000276:immunology; D002999:Clone Cells; D011905:Genes, ras; D006681:HLA-D Antigens / Q000276:immunology*; D006682:HLA-DP Antigens / Q000276:immunology; D006683:HLA-DQ Antigens / Q000276:immunology; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D016297:Mutagenesis, Site-Directed; D016283:Proto-Oncogene Proteins p21(ras) / Q000235:genetics / Q000276:immunology*; D011948:Receptors, Antigen, T-Cell / Q000235:genetics; D011994:Recombinant Proteins / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology*
chemical_list: D000911:Antibodies, Monoclonal; D006681:HLA-D Antigens; D006682:HLA-DP Antigens; D006683:HLA-DQ Antigens; D006684:HLA-DR Antigens; D011948:Receptors, Antigen, T-Cell; D011994:Recombinant Proteins; C501009:HRAS protein, human; D016283:Proto-Oncogene Proteins p21(ras)